Thursday, April 29, 2021


REBEL EM - April 29, 2021 - By Thomas del Ninno
Paper: Kaura A et al. Invasive Versus Non-Invasive Management of Older Patients with Non-ST Elevation Myocardial Infarction (SENIOR-NSTEMI): A Cohort Study Based on Routine Clinical Data. Lancet 2020. PMID: 328613074 [Open in Read by QxMD]
“Clinical Question: In patients ≥ 80 years of age with a NSTEMI is an invasive or non-invasive strategy associated with an improved mortality?
Author Conclusion:On the basis of routinely collected clinical data from five UK tertiary centres we found that invasive management in patients aged 80 years or older with NSTEMI was associated with 32% lower mortality, compared with non-invasive management. The survival advantage bestowed by invasive management might extend to patients aged 80 years or older with NSTEMI.”
Clinical Take Home Point: There was an association of higher rates of survival at 5 years and fewer subsequent admissions for heart failure in elderly patients (≥ 80 years of age) who were diagnosed with an NSTEMI and underwent invasive management when compared to a non-invasive approach.”